Maternal IgG Antibodies to SARS-CoV-2 Transferred Across Placenta
Maternal immunoglobulin G antibodies to SARS-CoV-2 are transferred across the placenta, and cord IgG concentrations are associated with maternal IgG concentrations.
Maternal immunoglobulin G antibodies to SARS-CoV-2 are transferred across the placenta, and cord IgG concentrations are associated with maternal IgG concentrations.
The randomized, placebo-controlled, observer-blind study is evaluating the safety, tolerability, and immunogenicity of BNT162b2 in approximately 4000 healthy pregnant women aged 18 years and older who are 24 to 34 weeks’ gestation.
Study authors evaluated the pregnancy experiences of women with rheumatic disease during the COVID-19 pandemic.
Study authors quantified SARS-CoV-2 viral load in maternal and neonatal biofluids, tranplacental movement of anti-SARS-CoV-2 antibody, and incidence of fetoplacental infection.
Prior to pregnancy, her viral load had been undetectable for more than 2 years.
Study authors sought to determine whether surgical antimicrobial prophylaxis administration following cord clamping led to an increase risk of surgical site infections.
In their presentation at The Liver Meeting, a team of investigators from the University of California, San Francisco sought to assess pregnancy outcomes in women with autoimmune hepatitis.
Chart showing pregnancy categories are assigned to drugs to define their risk of causing fetal harm during pregnancy. There are five pregnancy categories (A, B, C, D, and X).
This cross-sectional, web-based, national survey was conducted during the first month of full lockdown in Italy and participants were recruited via social networks.
Only 7% of mothers delivering at large county health system tested positive for COVID-19, as did 3% of tested infants.